ASK REDCHAT ANYTHING ABOUT SPERO THERAPEUTICS INC.
Spero Therapeutics Inc. (NASDAQ: SPRO)
Listen to this Section
$2.92
+0.1240
(
+4.43% )
185.3K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Tebipenem HBr (previously SPR994): oral carbapenemDetailsBacterial infection, Urinary tract infection |
Phase 3 |
| SPR206DetailsLung disease, Bacterial infection |
Phase 2 |
| SPR720DetailsLung disease, Bacterial infection |
Phase 2a |
| SPR720DetailsBacterial infection, Lung disease |
Failed |
Market Data
|
| Open |
$2.92 |
| Previous Close |
$2.80 |
| Volume |
185.3K |
| Market Cap |
$162.12M |
| Day Range |
$2.77 - $2.94 |
| 52 Week Range |
$1.80 - $3.22 |
| Shares Outstanding |
57.90M |
| Change % |
+4.43% |
| Net Change |
▲ 0.1240 |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2017 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-2,306,857.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-08-06 |
Sale |
-14800.00 |
Shukla Sath |
| 2024-05-30 |
Sale |
-20000.00 |
Jackson Scott Thomas |
| 2024-05-30 |
Sale |
-20000.00 |
Mahadevia Ankit |
| 2024-05-30 |
Sale |
-20000.00 |
Smith Cynthia |
| 2024-05-30 |
Sale |
-20000.00 |
THOMAS FRANK E |
| 2024-05-30 |
Sale |
-20000.00 |
Deshpande Milind |
| 2024-05-30 |
Sale |
-20000.00 |
VINK PATRICK V.J.J. |
| 2024-05-30 |
Sale |
-20000.00 |
Tregoning Kathleen |
| 2024-05-30 |
Sale |
-20000.00 |
Pottage John C Jr |
| 2024-02-05 |
Sale |
-239731.00 |
HAMED KAMAL |